0000000000008321
AUTHOR
Anna Di Prima
LA DOMOTICA A FAVORE DEGLI ANZIANI
I LUOGHI DELLA CURA E DEL MORIRE: REPARTO DI GERIATRIA: TRE ANNI DI ATTIVITÀ
MILD COGNITIVE IMPAIRMENT (MCI): LA ZONA GRIGIA
Ruolo del gene PNPLA3 nella suscettibilità genetica della suscettibilità genetica della steatosi epatica
Systemic Immune Responses in Alzheimer's Disease: In Vitro Mononuclear Cell Activation and Cytokine Production
To investigate the systemic signs of immune-inflammatory responses in Alzheimer's disease (AD), in the present study we have analyzed blood lymphocyte subsets and the expression of activation markers on peripheral blood mononuclear cells (PBMCs) from AD patients and age-matched healthy controls (HC) activated in vitro by recombinant amyloid-beta peptide (rAbeta42). Our study of AD lymphocyte subpopulations confirms the already described decrease of the absolute number and percentage of B cells when compared to HC lymphocytes, whereas the other subsets are not significantly different in patients and controls. We report the increased expression of the activation marker CD69 and of the chemoki…
RIABILITAZIONE NEUROMOTORIA NELLA M. DI PARKINSON: CONDIZIONAMENTO SENSORIALE
MALATTIA DI PARKINSON: FATTORI AMBIENTALI E GENETICI
TORRE DI LONDRA: DEMENZA FRONTO-TEMPORALE E DISTURBO DELL’ UMORE
PSEUDODEMENZA, DEPRESSIONE E DEMENZA
DEPRESSIONE, ANZIANI E PSICOTERAPIA
NECESSITÀ DEL RICOVERO IN RSA IN ALCUNI PAZIENTI CON DEMENZA DI ALZHEIMER. CASO CLINICO
CORRELAZIONE TRA DEMENZA E DEPRESSIONE. Studio su 60 pazienti ambulatoriali
Variations in the volatile compounds of a Fennel (Foeniculum vulgare Mill.) variety grown in a semi-arid Mediterranean environment
Fennel is an industrial source of anethole but, recently, further interest has came from the suggested possibility of many industrial uses of this plant. The volatile substances from the seeds of fennel grown in Sparacia (Cammarata - AG - Sicily; 37° 38' N; 13° 46' E) have been investigated and compared on a statistical base with previously reported data. The variety grown in Sparacia fall into the "high fenchone" chemovariety. The substances alpha-toluene, alpha-terpinene, beta-phellandrene + limonene and camphene appear the components most sensitive to environment and grow condition modifications. Fennel is an industrial source of anethole but, recently, further interest has come from the…
DEFICIT COGNITIVO E DIABETE. STUDIO OSSERVAZIONALE
MILD COGNITIVE IMPAIRMENT: LA ZONA GRIGIA
ATTUALE APPROCCIO TERAPEUTICO NEI PAZIENTI CON MALATTIA DI ALZHEIMER
DISTURBI DEL SONNO IN SOGGETTI ANZIANI
DEPRESSIONE E RISCHIO DI EVENTI CEREBROVASCOLARI ACUTI
TEST-AND-TREAT ANCHE PER LA POPOLAZIONE GERIATRICA CON HP-INFEZIONE?
DOMOTICA, UTENZA DEBOLE E ANZIANI
MALATTIA DI ALZHEIMER: PREDISPOSIZIONE, PREVENZIONE E TERAPIE FARMACOLOGICHE
CO-MORBILITA’ E DEPRESSIONE NELL’ANZIANO
L’ALIMENTAZIONE NEI PAZIENTI ISTITUZIONALIZZANTI AFFETTI DA DEMENZA TIPO ALZHEIMER
MALATTIA DI ALZHEIMER: PREDISPOSIZONE, PREVENZIONE E TERAPIE FARMACOLOGICHE
COENZIMA Q E MALATTIA DI PARKINSON
DEMENZA E DISTURBI DELL’ALIMENTAZIONE
NECESSITÀ DI UNA PERIODICA ASSISTENZA GERIATRICA DOMICILIARE. DESCRIZIONE DI UN CASO CLINICO
DEMENZE E RISCHIO DI FRATTURE OSTEOPOROTICHE NEGLI ANZIANI. STUDIO OSSERVAZIONALE IN UN’UNITA’ VALUTATIVA ALZHEIMER (n°6) DI PALERMO
DEPRESSIONE E DEMENZA: STUDIO NEUROPSICOLOGICO
SINTOMI COGNITIVI E DEPRESSIVI IN SOGGETTI NON DEMENTI CON MALATTIA CEREBROVASCOLARE SOTTOCORTICALE
PARKINSON E DEMENZA : VALUTAZIONE COMPARATIVA TRA INDICI NEUROPSICOLOGICI E NEURORADIOLOGICI
Celiac disease: a cause of unexplained elevated serum pancreatic enzymes
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD).
Acetylcholinesterase inhibitors (AchEIs) are extensively used in Alzheimer's disease (AD) while reality orientation therapy (ROT) is a cognitive rehabilitation indicated for mentally deteriorated patients. We aimed to evaluate the efficacy of the combination of donepezil with an intensive ROT with active participation of the caregiver. Patients with AD (n=100, mean age 78.4±4.3 years) initiated treatment with donepezil, 5mg/day; 62 of them underwent a 3-week, daily ROT and physical reactivation training with the caregiver (Group A); 38 participants received only donepezil therapy (Group B). All subjects were tested for cognitive and functional abilities at baseline, at the end of the traini…